All in all, in silico data from database, clinical data collected on glioblastoma fresh-frozen samples, together with cellular and molecular data on engineered immortalized and primary cell lines, suggest a potential role of PLCβ1 in maintaining a normal or less aggressive phenotype of glioma (Fig. 9). The gene discussed is PLCB1; the disease is central nervous system cancer.